Specialty code 183500000X · Sacramento, CA
NPI
1023484540
Since 2015
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
6600 Bruceville Rd
Sacramento, CA, 95823
Phone (916) 688-2000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$391K
2,054 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Anchieh Ouyang prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 246 prescriptions and refills. In total Anchieh Ouyang wrote 2,054 Medicare prescriptions that cost $391K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Er Metformin Hcl | 246 | 806 | 110 | $2,493 |
| Atorvastatin Calcium Generic | 227 | 757 | 101 | $2,768 |
| Ozempic Semaglutide | 195 | 198 | 31 | $144K |
| Metformin Hcl Generic | 137 | 452 | 57 | $1,681 |
| Glipizide Generic | 137 | 441 | 64 | $1,640 |
| Jardiance Empagliflozin | 117 | 362 | 46 | $60K |
| Humulin N Insulin Nph Human Isophane | 112 | 340 | 57 | $21K |
| Insulin Glargine-Yfgn Generic | 99 | 303 | 56 | $13K |
| Humulin R Insulin Regular, Human | 92 | 277 | 37 | $16K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 90 | 274 | 46 | $2,150 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 76 | 246 | 41 | $2,109 |
| Glipizide Er Glipizide | 56 | 184 | 21 | $1,596 |
| Victoza 2-Pak Liraglutide | 41 | 41 | 13 | $26K |
| Amlodipine Besylate Generic | 40 | 133 | 22 | $536 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 40 | 104 | 24 | $6,916 |
Brand drugs: 812 claims; generic drugs: 1,024 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Anchieh Ouyang were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.